| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |